The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Establishment of Human Papillomavirus Infection Requires Cell Cycle Progression
Open accessAbstract
Human papillomaviruses (HPVs) are DNA viruses associated with major human cancers. As such there is a strong interest in developing new means, such as vaccines and microbicides, to prevent HPV infections. Developing the latter requires a better understanding of the infectious life cycle of HPVs. The HPV infectious life cycle is closely linked to the differentiation state of the stratified epithelium it infects, with progeny virus only made in the terminally differentiating suprabasal compartment. It has long been recognized that HPV must first establish its infection within the basal layer of stratified epithelium, but why this is the case has not been understood. In part this restriction might reflect specificity of expression of entry receptors. However, this hypothesis could not fully explain the differentiation restriction of HPV infection, since many cell types can be infected with HPVs in monolayer cell culture. Here, we used chemical biology approaches to reveal that cell cycle progression through mitosis is critical for HPV infection. Using infectious HPV16 particles containing the intact viral genome, G1-synchronized human keratinocytes as hosts, and early viral gene expression as a readout for infection, we learned that the recipient cell must enter M phase (mitosis) for HPV infection to take place. Late M phase inhibitors had no effect on infection, whereas G1, S, G2, and early M phase cell cycle inhibitors efficiently prevented infection. We conclude that host cells need to pass through early prophase for successful onset of transcription of the HPV encapsidated genes. These findings provide one reason why HPVs initially establish infections in the basal compartment of stratified epithelia. Only this compartment of the epithelium contains cells progressing through the cell cycle, and therefore it is only in these cells that HPVs can establish their infection. By defining a major condition for cell susceptibility to HPV infection, these results also have potentially important implications for HPV control.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Individual factors unique to the mucosal surface such as epithelial surface integrity, mucosal secretions, and immune regulation likely play a role in HPV persistence and progression to cancer (Pyeon et al., 2009; Schiffman et al., 2016).”
From Viral Infections, the Microbiome, and Probiotics (2021) · cites this paper as Pyeon et al., 2009
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Primer3 on the WWW for General Users and for Biologist Programmers
Rozen, S., & Skaletsky, H. (2003) · Humana Press eBooks · doi:10.1385/1-59259-192-2:365 · Cited by 15,068
Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line.
Boukamp, P., Petrussevska, R. T., Breitkreutz, D., Hornung, J., Markham, A., & Fusenig, N. E. (1988) · The Journal of cell biology · doi:10.1083/jcb.106.3.761 · Cited by 4,170
Papillomaviruses and cancer: from basic studies to clinical application
Hausen, H. Z. (2002) · Nature reviews. Cancer · doi:10.1038/nrc798 · Cited by 4,031
Human papillomavirus and cervical cancer
Burd, E. M. (2003) · Clinical Microbiology Reviews · doi:10.1128/cmr.16.1.1-17.2003 · Cited by 2,420
Small Molecule Inhibitor of Mitotic Spindle Bipolarity Identified in a Phenotype-Based Screen
Mayer, T. U., Kapoor, T. M., Haggarty, S. J., King, R. W., Schreiber, S. L., & Mitchison, T. J. (1999) · Science · doi:10.1126/science.286.5441.971 · Cited by 1,752
Papillomavirus infections — a major cause of human cancers
Hausen, H. Z. (1996) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(96)00020-0 · Cited by 1,532
Cdk1 is sufficient to drive the mammalian cell cycle
Santamarı́a, D., Barrière, C., Cerqueira, A., Hunt, S. L., Tardy, C., Newton, K., Cáceres, J. F., Dubus, P. R., Malumbres, M., & Barbacid, M. (2007) · Nature · doi:10.1038/nature06046 · Cited by 1,096
Structure, dynamics and functions of promyelocytic leukaemia nuclear bodies
Bernardi, R., & Pandolfi, P. P. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2277 · Cited by 876
Exploiting Chemical Libraries, Structure, and Genomics in the Search for Kinase Inhibitors
Gray, N. S., Wodicka, L. M., Thunnissen, A. M. W. H., Norman, T., Kwon, S., Espinoza, F. H., Morgan, D. O., Barnes, G., Leclerc, S., Meijer, L., et al. (1998) · Science · doi:10.1126/science.281.5376.533 · Cited by 808
Lewis, P. F., & Emerman, M. (1994) · Journal of Virology · doi:10.1128/jvi.68.1.510-516.1994 · Cited by 797
Flagged first, then by citations
Cited by
Sorted by citations
Items 301–348 of 348
Rao, A., Ni, Z., Suresh, D., Mohanty, C., Wang, A. R., Lee, D. L., Nickel, K. P., Varambally, S., Kimple, R. J., Lambert, P. F., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.10.02.560587 · Cited by 1
Feng, Y., van Bodegraven, D., Kádek, A., Munguira, I. L. B., Soria-Martínez, L., Nentwich, S., Kavan, D., Uetrecht, C., Schelhaas, M., & Roos, W. H. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.02.01.577804 · Cited by 1
Gradíssimo, A. (2014) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Wendel, S. B. (2009) · Figshare
Müller, S. (2013) · Figshare
Características do genoma humano associadas à integração do HIV - análise bioinformática
Gonçalves, J. (2014) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
DigitalCommons@Th e Texas Medical Center
Gsbs, U., & Hong, J. Y. (2011)
Анатольевич, Е. В., Семёнович, Ч. В., & Lisyanskaya, A. S. (2015) · P A Herzen Journal of Oncology · doi:10.17116/onkolog20154224-28
Papillomavirus L2-Dependent Endocytosis and Subcellular Trafficking
Lu, M. (2016) · UA Campus Repository (The University of Arizona)
Role of Cancer Stem Cells in Oral Cancer
Suresh, A., Naik, R. R., & Bapat, S. A. (2016) · Springer eBooks · doi:10.1007/978-3-319-14911-0_13
Li, S. (2016) · UA Campus Repository (The University of Arizona)
Development of prophylactic human papillomavirus vaccines
Kwak, K. (2014)
HPV in Head and Neck Cancer: Diagnosis
Jung, Y. (2012) · Journal of Clinical Otolaryngology Head and Neck Surgery · doi:10.35420/jcohns.2012.23.1.17
Kożańska, A., Pisarska, J., & Baldy-Chudzik, K. (2019) · World Scientific News
Immune Targeting of Oncogenic HPV as Therapy for Cancer
Stern, P. L. (2020) · Springer eBooks · doi:10.1007/978-3-030-50287-4_28
Hepatitis B Surface Antigen-based Vaccines for Human Neoplastic Disease
Haigh, O. L. (2010) · The University of Queensland · doi:10.14264/uql.2018.520
Articles of Significant Interest in This Issue
(2018) · Journal of Virology · doi:10.1128/jvi.01514-18
Pathogenesis and immune response against HPV infection
Sahu, U., & Khare, P. S. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-91797-1.00006-5
Papillomaviruses and Cervical Neoplasia
Herfs, M. F., Crum, C. P., & Münger, K. (2022) · Wiley eBooks · doi:10.1002/9781119000822.hfcm030.pub2
Li, S., Williamson, Z. L., Christofferson, M. A., Jeevanandam, A., & Campos, S. K. (2024) · Tumour Virus Research · doi:10.1016/j.tvr.2024.200287
Identification of new host factors supporting the human papillomavirus life cycle
Ishii, Y., Mori, S., & Kukimoto, I. (2023) · Uirusu · doi:10.2222/jsv.73.189
Bacterial–Viral Coinfections in Cervical Cancer
Frank, S. (2024) · IntechOpen eBooks · doi:10.5772/intechopen.115009
Amusan, O. T., Lopez, R., Burks, E., Trammel, J., Raikhy, G., Guo, H., & Bodily, J. M. (2025) · Viruses · doi:10.3390/v17050598
L1 Capsid Protein Expression in HPV-Positive Barrett Metaplasia-Dysplasia-Adenocarcinoma Lesions
Vythilingam, D. I., Gautam, S. D., Santos, L. D., Xuan, W., Rabiei, M., & Rajendra, S. (2025) · Clinical and Translational Gastroenterology · doi:10.14309/ctg.0000000000000853
Therapeutic approaches and complications in the treatment of precancerous changes of the cervix
Dikova, G., Kirkova, M., & Kirkov, V. (2025) · Pharmacia · doi:10.3897/pharmacia.72.e164999
E2 Tyrosine 102 Regulates MmuPV1 Pathogenesis In Vivo
González, J., DeSmet, M. L., Stoll, K., Jose, L., Christensen, N. D., & Androphy, E. J. (2025) · Pathogens · doi:10.3390/pathogens14090913
Codon usage of human DNA viruses and its similarity to certain host genes
Sirihongthong, T., Jitobaom, K., Boonarkart, C., sheerazi, K., & Auewarakul, P. (2025) · Scientific Reports · doi:10.1038/s41598-025-27070-1
Filamentous virions act as non-infectious interfering particles to modulate papillomavirus infection
van Bodegraven, D., Saha, S., Greune, L., Kirnbauer, R., Dersch, P., & Schelhaas, M. (2026) · Journal of Virology · doi:10.1128/jvi.02039-25
Hyperactivated YAP1 Drives an Invasive EMT Subtype of Cervical Squamous Cell CarcinomaPreprint
Liu, J., Lv, X., Ruan, J., He, C., Hua, G., Chen, P., Zhao, X., Shi, D., Yang, S., Polakkottil, A., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.01.18.700207
Caractérisation des fonctions cellulaires du facteur de restriction viral APOBEC3A
Niocel, M. (2017) · theses.fr (ABES) · doi:10.70675/b688234az5bc7z4100zb26ez7528ceb4c3ae
Brancaccio, R. N. (2020) · theses.fr (ABES) · doi:10.70675/b9d29e13z941fz4bdezbed3zcb7b5813f658
Epstein–Barr Virus and Human Papillomavirus Co‐Infections in Epithelial Carcinomas
Nkadi, E. H., Schaal, D. L., & Scott, R. S. (2026) · Journal of Medical Virology · doi:10.1002/jmv.70935
Ishii, Y., & Kukimoto, I. (2026) · FEBS Letters · doi:10.1002/1873-3468.70365
Human papillomavirus in cancer: Pathogenesis and vaccination approaches
Maré, M. G. J., & Balmith, M. (2026) · SA pharmaceutical journal. · doi:10.36303/sapj.4381
In Situ Cryo-ET Redefines HPV Entry Paradigm
Sutanto, R., Rana, J. K., Tsai, B., & Mosalaganti, S. (2026) · Microscopy and Microanalysis · doi:10.1093/mam/ozag053.380
Differentiation-independent activation of HPV genome replication by the lncRNA DINO
Arman, W., McBride, A. A., & Münger, K. (2026) · mBio · doi:10.1128/mbio.01443-26
Outcome of human papillomavirus infection among men in the Finnish Family HPV Study
Kero, K. (2014) · UTUPub (University of Turku)
Metadata
- Authors
- Pyeon, D., Pearce, S. M., Lank, S. M., Ahlquist, P., & Lambert, P. F.
- Affiliations
- University of Wisconsin–Madison (US)
- Howard Hughes Medical Institute (US)
- Corresponding author
- Ahlquist, Paul
- Lambert, Paul F.
- Venue
- PLoS Pathogens
- Publisher
- Public Library of Science (PLoS)
- Published
- 2009-02-27
- Volume
- 5
- Issue
- 2
- Pages
- e1000318
- ISSN
- 1553-7366 (ISSN-L)
- 1553-7374
- PMC
- PMC2642596
- OpenAlex
- W2074766470
- Cited by
- 348
- References
- 52
- Citations by year
- 2026: 14 · 2025: 22 · 2024: 22 · 2023: 17 · 2022: 16 · 2021: 27 · 2020: 19 · 2019: 25 · 2018: 17 · 2017: 25 · 2016: 26 · 2015: 24 · 2014: 20 · 2013: 30 · 2012: 15
- FWCI
- 9.85
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS Pathogens (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- Howard Hughes Medical Institute
- University of Wisconsin-Madison
- National Institutes of Health (CA022443)
- National Cancer Institute (CA022443, P01CA022443)
- National Institute of Allergy and Infectious Diseases (R33AI071947, AI071947, R21AI071947)
- Topics
- Health Sciences › Medicine › Epidemiology › Cervical Cancer and HPV Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Keywords
- human papillomavirus, HPV16, cell cycle progression, mitosis, stratified epithelium, keratinocytes, G1 phase, viral gene expression, microbicides, HPV vaccine, viral entry receptor
- MeSH terms
- Antiviral Agents, Cell Cycle, Cell Division, Cell Survival, Cells, Cultured, Etoposide, Humans, Orthomyxoviridae, Prophase, Transcription, Genetic, Virion, Keratinocytes, Gene Expression Regulation, Viral, Aphidicolin, Genome, Viral, Human papillomavirus 16
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review